Abstract | BACKGROUND: Microporous polysaccharide hemospheres consist of controlled-porosity spherical particles manufactured from bioinert plant polysaccharide. Microporous polysaccharide hemospheres facilitate hemostasis by rapidly absorbing the fluid component of blood, concentrating platelets and clotting factors to accelerate blood clotting. OBJECTIVE: METHODS: RESULTS: Nineteen patients not taking anticoagulants had 40 stages, of which 18 received the study bandage and 22 received electrocautery. The remaining 5 patients on anticoagulants had 8 stages, of which 4 received the study bandage and 4 received electrocautery. In both total and subgroup analysis, there was a higher incidence of bleeding through the dressing with the study bandage (p<0.05), but no increase in the incidence of active bleeding upon dressing removal (p>0.05). CONCLUSION:
|
Authors | Stephen R Tan, Whitney D Tope |
Journal | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
(Dermatol Surg)
Vol. 30
Issue 6
Pg. 908-14
(Jun 2004)
ISSN: 1076-0512 [Print] United States |
PMID | 15171770
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Polysaccharides
- Sclerosing Solutions
|
Topics |
- Aged
- Electrocoagulation
(methods)
- Female
- Hemostatic Techniques
- Humans
- Male
- Middle Aged
- Mohs Surgery
(methods)
- Occlusive Dressings
- Polysaccharides
(administration & dosage)
- Postoperative Hemorrhage
(prevention & control)
- Prospective Studies
- Sclerosing Solutions
(administration & dosage)
- Skin Neoplasms
(physiopathology, surgery)
- Treatment Outcome
- Wound Healing
|